These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29154986)

  • 1. GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal Cell Carcinoma Cells Both In Vitro and In Vivo.
    Kim GE; Jung AR; Kim MY; Lee JB; Im JH; Lee KW; Park YH; Lee JY
    Urology; 2018 Mar; 113():129-137. PubMed ID: 29154986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.
    Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma.
    Sasamura H; Takahashi A; Yuan J; Kitamura H; Masumori N; Miyao N; Itoh N; Tsukamoto T
    Urology; 2004 Aug; 64(2):389-93. PubMed ID: 15302513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.
    Park JK; Kim Y; Kim H; Jeon J; Kim TW; Park JH; Hwnag YI; Lee WJ; Kang JS
    Oncotarget; 2016 Nov; 7(46):75081-75093. PubMed ID: 27655706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1α-VEGF signaling axis.
    Kim BK; Kim BR; Lee HJ; Lee SA; Kim BJ; Kim H; Won YS; Shon WJ; Lee NR; Inn KS; Kim BJ
    Biomaterials; 2014 Mar; 35(9):2924-33. PubMed ID: 24411674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
    BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo.
    He Y; Jiang Y; Li YJ; Liu XH; Zhang L; Liu LJ; Shi H; Li HN; Ma YC; Jin XM
    J Gastroenterol Hepatol; 2010 May; 25(5):935-41. PubMed ID: 20546447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
    Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
    Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of peptide GV1001 against renal ischemia-reperfusion injury in mice.
    Koo TY; Yan JJ; Yang J
    Transplant Proc; 2014 May; 46(4):1117-22. PubMed ID: 24815142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
    Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
    Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent.
    Xiong Z; Zang Y; Zhong S; Zou L; Wu Y; Liu S; Fang Z; Shen Z; Ding Q; Chen S
    Oncotarget; 2017 May; 8(18):30151-30161. PubMed ID: 28404914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinoma.
    Asakuma J; Sumitomo M; Asano T; Asano T; Hayakawa M
    J Urol; 2004 Feb; 171(2 Pt 1):897-902. PubMed ID: 14713849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
    Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
    BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage.
    Zhu M; Li Y; Zhou Z
    Biochem Biophys Res Commun; 2017 Oct; 492(3):373-378. PubMed ID: 28847725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
    Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
    Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.